KKR to Buy Integer Holdings for $5.7 Billion in All-Cash Deal
Shareholders get cash; company goes private by year-end.
Already have an account? Sign in.
Shareholders get cash; company goes private by year-end.
Skye Bioscience acquires Redx Pharma via UK scheme of arrangement. Combined company Fibrx focuses on RXC008 for Crohn’s fibrosis. Skye holders get only 5.38%.
FDA review papers reveal encouraging Week 52 eGFR findings (+5.2 placebo-adjusted) for TRUTAKNA in primary IgA nephropathy patients.
Key reason: rapid shift to >90% AI revenue and exclusive position in high-power reliability testing for advanced chips.